Occupational Exposure in Health Care Personnel to Antineoplastic Drugs and Initiation of Safe Handling in Hong Kong A Literature Review

被引:8
作者
Yu, Emily [1 ]
机构
[1] ICU Med HK Ltd, Kowloon Bay, Hong Kong, Peoples R China
关键词
antineoplastic drugs; chemotherapy; cytotoxic drugs; hazardous drugs; nurse safety; occupational exposure; PPE; safe handling precautions; side effects; surface sampling; working conditions; ONCOLOGY NURSES; CYTOSTATIC THERAPY; LYMPHOCYTES; CANCER; CONTAMINATION; WORKERS; PREGNANCY; DAMAGE; RISK; PRECAUTIONS;
D O I
10.1097/NAN.0000000000000361
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Despite the benefits for patients as cancer treatment, antineoplastic drugs may cause adverse effects not only in patients but also in health care personnel. Apart from minor symptoms, antineoplastic agents can cause serious health problems. However, protection from occupational exposures to antineoplastic drugs varies between pharmacy staff and nurses. While protection used for pharmacy staff are more advanced, personal protective equipment seems to be the only protection for most nurses around the world. Exposure can never be totally prevented, but it should be minimized at all costs. Guidelines and recommendations have been published; however, these guidelines do not have legal enforcement power. This article aims to provide a literature review on the occupational exposure of health care personnel to antineoplastic drugs and to reflect the current status in Hong Kong.
引用
收藏
页码:121 / 133
页数:13
相关论文
共 76 条
[1]  
American Society of Health-System Pharmacists, 2018, ASHP GUID HANDL HAZ
[2]  
[Anonymous], 2004, NIOSH AL PREV OCC EX
[3]  
[Anonymous], 2015, FISC MAL PRAX FE MED
[4]  
[Anonymous], 2016, CCOO CNS VIS RIES MA
[5]   ACUTE AND LONG-TERM CYTOGENETIC EFFECTS OF TREATMENT IN CHILDHOOD-CANCER - SISTER-CHROMATID EXCHANGES AND CHROMOSOME-ABERRATIONS [J].
ARONSON, MM ;
MILLER, RC ;
HILL, RB ;
NICHOLS, WW ;
MEADOWS, AT .
MUTATION RESEARCH, 1982, 92 (1-2) :291-307
[6]  
Australian Government, 2018, ACT REL WORK HLTH SA
[7]  
Baniasadi S, 2018, IRAN J PHARM RES, V17, P1458
[8]   Assessment of genotoxic damage in nurses occupationally exposed to antineoplastics by the analysis of chromosomal aberrations [J].
Burgaz, S ;
Karahalil, B ;
Canli, Z ;
Terzioglu, F ;
Ançel, G ;
Anzion, RBM ;
Bos, RP ;
Hüttner, E .
HUMAN & EXPERIMENTAL TOXICOLOGY, 2002, 21 (03) :129-135
[9]   Multicentre study for the evaluation of mutagenic/carcinogenic risk in nurses exposed to antineoplastic drugs: assessment of DNA damage [J].
Buschini, Annamaria ;
Villarini, Milena ;
Feretti, Donatella ;
Mussi, Francesca ;
Dominici, Luca ;
Zerbini, Ilaria ;
Moretti, Massimo ;
Ceretti, Elisabetta ;
Bonfiglioli, Roberta ;
Carrieri, Mariella ;
Gelatti, Umberto ;
Rossi, Carlo ;
Monarca, Silvano ;
Poli, Paola .
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2013, 70 (11) :789-794
[10]   Cytogenetic analysis in peripheral lymphocytes of cancer patients treated with cytostatic drugs: Results from an EC Collaborative Study [J].
Carbonell, E ;
Demopoulos, NA ;
Stefanou, G ;
Psaraki, K ;
Parry, EM ;
Marcos, R .
ANTI-CANCER DRUGS, 1996, 7 (05) :514-519